{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:49:11Z","timestamp":1782762551040,"version":"3.54.5"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06562-3","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:22:26Z","timestamp":1782760946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3514-1394","authenticated-orcid":false,"given":"Selcuk","family":"Erdem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Amparore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samed","family":"Verep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Capitanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Muselaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onder","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Ingels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savio Domenico","family":"Pandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Carbonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Borregales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cali\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Alberto","family":"Lovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ciccarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Margue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Francolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Flippot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Kawai","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Mjaess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carme","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of EAU-YAU Renal Cancer Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"6562_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9343(64)90107-X","volume":"36","author":"KL Melmon","year":"1964","unstructured":"Melmon KL, Rosen SW (1964) Lindau\u2019s disease. Am J Med 36:595\u2013617. https:\/\/doi.org\/10.1016\/0002-9343(64)90107-X","journal-title":"Am J Med"},{"key":"6562_CR2","first-page":"30","volume-title":"Frontiers of hormone research","author":"A Chou","year":"2013","unstructured":"Chou A, Toon C, Pickett J, Gill AJ (2013) von Hippel-Lindau Syndrome. In: Stratakis CA (ed) Frontiers of hormone research. S. Karger, AG, pp 30\u201349"},{"key":"6562_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/jmg.28.7.443","volume":"28","author":"ER Maher","year":"1991","unstructured":"Maher ER, Iselius L, Yates JR et al (1991) Von Hippel-Lindau disease: a genetic study. J Med Genet 28:443\u2013447. https:\/\/doi.org\/10.1136\/jmg.28.7.443","journal-title":"J Med Genet"},{"key":"6562_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2011-100562","volume":"49","author":"A Wilding","year":"2012","unstructured":"Wilding A, Ingham SL, Lalloo F et al (2012) Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 49:264\u2013269. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100562","journal-title":"J Med Genet"},{"key":"6562_CR5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1586\/ern.11.124","volume":"11","author":"JJ Wind","year":"2011","unstructured":"Wind JJ, Lonser RR (2011) Management of von Hippel\u2013Lindau disease-associated CNS lesions. Expert Rev Neurother 11:1433\u20131441. https:\/\/doi.org\/10.1586\/ern.11.124","journal-title":"Expert Rev Neurother"},{"key":"6562_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/MOU.0000000000000950","volume":"32","author":"A Larcher","year":"2022","unstructured":"Larcher A, Rowe I, Belladelli F et al (2022) Von Hippel\u2013Lindau disease-associated renal cell carcinoma: a call to action. Curr Opin Urol 32:31\u201339. https:\/\/doi.org\/10.1097\/MOU.0000000000000950","journal-title":"Curr Opin Urol"},{"key":"6562_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S (2011) Von Hippel\u2013Lindau disease: a clinical and scientific review. Eur J Hum Genet 19:617\u2013623. https:\/\/doi.org\/10.1038\/ejhg.2010.175","journal-title":"Eur J Hum Genet"},{"key":"6562_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/bju.70078","volume":"137","author":"C Re","year":"2026","unstructured":"Re C, Amparore D, Campi R et al (2026) Awareness and perspectives on hereditary renal cell carcinoma and genetic testing in clinical practice: a multi-national survey. BJU Int 137:456\u2013459. https:\/\/doi.org\/10.1111\/bju.70078","journal-title":"BJU Int"},{"key":"6562_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","volume":"32","author":"B Shuch","year":"2014","unstructured":"Shuch B, Vourganti S, Ricketts CJ et al (2014) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. JCO 32:431\u2013437. https:\/\/doi.org\/10.1200\/JCO.2013.50.8192","journal-title":"JCO"},{"key":"6562_CR10","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1111\/j.1464-410X.2010.09441.x","volume":"106","author":"MK Tollefson","year":"2010","unstructured":"Tollefson MK, Boorjian SA, Lohse CM et al (2010) The impact of family history on pathological and clinical outcomes in non-syndromic clear cell renal cell carcinoma. BJU Int 106:1638\u20131642. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09441.x","journal-title":"BJU Int"},{"key":"6562_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/JU.0000000000001911","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Clark PE, Chang SS et al (2021) Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: Part I. J Urol 206:199\u2013208. https:\/\/doi.org\/10.1097\/JU.0000000000001911","journal-title":"J Urol"},{"key":"6562_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex A, Ghanem YA, Albiges L et al (2025) European association of urology guidelines on renal cell carcinoma: the 2025 update. Eur Urol 87:683\u2013696. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.020","journal-title":"Eur Urol"},{"key":"6562_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/medsci12010012","volume":"12","author":"GA Yanus","year":"2024","unstructured":"Yanus GA, Kuligina ES, Imyanitov EN (2024) Hereditary renal cancer syndromes. Med Sci 12:12. https:\/\/doi.org\/10.3390\/medsci12010012","journal-title":"Med Sci"},{"key":"6562_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s00261-016-0743-6","volume":"41","author":"A Kawashima","year":"2016","unstructured":"Kawashima A, Young SW, Takahashi N et al (2016) Inherited renal carcinomas. Abdom Radiol 41:1066\u20131078. https:\/\/doi.org\/10.1007\/s00261-016-0743-6","journal-title":"Abdom Radiol"},{"key":"6562_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.15586\/jkcvhl.2017.88","volume":"4","author":"N Varshney","year":"2017","unstructured":"Varshney N, Kebede AA, Owusu-Dapaah H et al (2017) A review of Von Hippel-Lindau syndrome. jkcvhl 4:20\u201329. https:\/\/doi.org\/10.15586\/jkcvhl.2017.88","journal-title":"jkcvhl"},{"key":"6562_CR16","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1136\/jmg.39.7.e38","volume":"39","author":"C Cybulski","year":"2002","unstructured":"Cybulski C, Krzystolik K, Murgia A et al (2002) Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene. J Med Genet 39:e38\u2013e38. https:\/\/doi.org\/10.1136\/jmg.39.7.e38","journal-title":"J Med Genet"},{"key":"6562_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/jmedgenet-2016-104058","volume":"54","author":"MLM Binderup","year":"2017","unstructured":"Binderup MLM, Jensen AM, Budtz-J\u00f8rgensen E, Bisgaard ML (2017) Survival and causes of death in patients with von Hippel-Lindau disease. J Med Genet 54:11\u201318. https:\/\/doi.org\/10.1136\/jmedgenet-2016-104058","journal-title":"J Med Genet"},{"key":"6562_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J et al (1993) Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene. Science 260:1317\u20131320. https:\/\/doi.org\/10.1126\/science.8493574","journal-title":"Science"},{"key":"6562_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1472-6483(10)61617-3","volume":"5","author":"S Rechitsky","year":"2002","unstructured":"Rechitsky S, Verlinsky O, Chistokhina A et al (2002) Preimplantation genetic diagnosis for cancer predisposition. Reprod Biomed Online 5:148\u2013155. https:\/\/doi.org\/10.1016\/S1472-6483(10)61617-3","journal-title":"Reprod Biomed Online"},{"key":"6562_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan WM, Srinivasan R, Schmidt LS (2010) The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 7:277\u2013285. https:\/\/doi.org\/10.1038\/nrurol.2010.47","journal-title":"Nat Rev Urol"},{"key":"6562_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins CE, Kaelin WG, Pavletich NP (1999) Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284:455\u2013461. https:\/\/doi.org\/10.1126\/science.284.5413.455","journal-title":"Science"},{"key":"6562_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage L, Eisen T, Maher ER (2015) VHL, the story of a tumour suppressor gene. Nat Rev Cancer 15:55\u201364. https:\/\/doi.org\/10.1038\/nrc3844","journal-title":"Nat Rev Cancer"},{"key":"6562_CR23","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-06-2510","volume":"13","author":"G Bratslavsky","year":"2007","unstructured":"Bratslavsky G, Sudarshan S, Neckers L, Linehan WM (2007) Pseudohypoxic pathways in renal cell carcinoma. Clin Cancer Res 13:4667\u20134671. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2510","journal-title":"Clin Cancer Res"},{"key":"6562_CR24","first-page":"514","volume":"24","author":"AG Knudson","year":"1972","unstructured":"Knudson AG, Strong LC (1972) Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet 24:514\u2013532","journal-title":"Am J Hum Genet"},{"key":"6562_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev.ge.20.120186.001311","volume":"20","author":"AG Knudson","year":"1986","unstructured":"Knudson AG (1986) Genetics of human cancer. Annu Rev Genet 20:231\u2013251. https:\/\/doi.org\/10.1146\/annurev.ge.20.120186.001311","journal-title":"Annu Rev Genet"},{"key":"6562_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1086\/302726","volume":"66","author":"MT Sgambati","year":"2000","unstructured":"Sgambati MT, Stolle C, Choyke PL et al (2000) Mosaicism in von Hippel\u2013Lindau Disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet 66:84\u201391. https:\/\/doi.org\/10.1086\/302726","journal-title":"Am J Hum Genet"},{"key":"6562_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/humu.20082","volume":"24","author":"C Gallou","year":"2004","unstructured":"Gallou C, Chauveau D, Richard S et al (2004) Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat 24:215\u2013224. https:\/\/doi.org\/10.1002\/humu.20082","journal-title":"Hum Mutat"},{"key":"6562_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/humu.20385","volume":"28","author":"KR Ong","year":"2007","unstructured":"Ong KR, Woodward ER, Killick P et al (2007) Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat 28:143\u2013149. https:\/\/doi.org\/10.1002\/humu.20385","journal-title":"Hum Mutat"},{"key":"6562_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s004390000265","volume":"106","author":"F Hes","year":"2000","unstructured":"Hes F, Zewald R, Peeters T et al (2000) Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene. Hum Genet 106:425\u2013431. https:\/\/doi.org\/10.1007\/s004390000265","journal-title":"Hum Genet"},{"key":"6562_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21219","author":"M Nordstrom-O\u2019Brien","year":"2010","unstructured":"Nordstrom-O\u2019Brien M, Van Der Luijt RB, Van Rooijen E et al (2010) Genetic analysis of von Hippel-Lindau disease. Hum Mutat. https:\/\/doi.org\/10.1002\/humu.21219","journal-title":"Hum Mutat"},{"key":"6562_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1200\/JCO.2005.02.2574","volume":"24","author":"RJ Motzer","year":"2006","unstructured":"Motzer RJ, Michaelson MD, Redman BG et al (2006) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. JCO 24:16\u201324. https:\/\/doi.org\/10.1200\/JCO.2005.02.2574","journal-title":"JCO"},{"key":"6562_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","volume":"76","author":"ER Maher","year":"1997","unstructured":"Maher ER, Kaelin WG (1997) Von Hippel-Lindau disease. Medicine (Baltimore) 76:381\u2013391. https:\/\/doi.org\/10.1097\/00005792-199711000-00001","journal-title":"Medicine (Baltimore)"},{"key":"6562_CR33","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M et al (2003) von Hippel-Lindau disease. Lancet 361:2059\u20132067. https:\/\/doi.org\/10.1016\/S0140-6736(03)13643-4","journal-title":"Lancet"},{"key":"6562_CR34","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00345-020-03441-3","volume":"39","author":"J Chahoud","year":"2021","unstructured":"Chahoud J, McGettigan M, Parikh N et al (2021) Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease. World J Urol 39:2409\u20132415. https:\/\/doi.org\/10.1007\/s00345-020-03441-3","journal-title":"World J Urol"},{"key":"6562_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.rcl.2015.12.004","volume":"54","author":"KP Shanbhogue","year":"2016","unstructured":"Shanbhogue KP, Hoch M, Fatterpaker G, Chandarana H (2016) Von Hippel-Lindau disease. Radiol Clin North America 54:409\u2013422. https:\/\/doi.org\/10.1016\/j.rcl.2015.12.004","journal-title":"Radiol Clin North America"},{"key":"6562_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2009.01281.x","volume":"77","author":"M Poulsen","year":"2010","unstructured":"Poulsen M, Budtz-J\u00f8rgensen E, Bisgaard M (2010) Surveillance in von Hippel\u2010Lindau disease (vHL). Clin Genet 77:49\u201359. https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01281.x","journal-title":"Clin Genet"},{"key":"6562_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-444-62702-5.00010-X","volume":"132","author":"P Chittiboina","year":"2015","unstructured":"Chittiboina P, Lonser RR (2015) Von Hippel-Lindau disease. Handb Clin Neurol 132:139\u2013156. https:\/\/doi.org\/10.1016\/B978-0-444-62702-5.00010-X","journal-title":"Handb Clin Neurol"},{"key":"6562_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-198901000-00001","volume":"68","author":"JM Lamiell","year":"1989","unstructured":"Lamiell JM, Salazar FG, Hsia YE (1989) Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 68:1\u201329. https:\/\/doi.org\/10.1097\/00005792-198901000-00001","journal-title":"Medicine"},{"key":"6562_CR39","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ki.1996.395","volume":"50","author":"D Chauveau","year":"1996","unstructured":"Chauveau D, Duvic C, Chr\u00e9tien Y et al (1996) Renal involvement in von Hippel-Lindau disease. Kidney Int 50:944\u2013951. https:\/\/doi.org\/10.1038\/ki.1996.395","journal-title":"Kidney Int"},{"key":"6562_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","volume":"194","author":"PL Choyke","year":"1995","unstructured":"Choyke PL, Glenn GM, Walther MM et al (1995) Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194:629\u2013642. https:\/\/doi.org\/10.1148\/radiology.194.3.7862955","journal-title":"Radiology"},{"key":"6562_CR41","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1200\/JCO.19.02263","volume":"38","author":"MW Ball","year":"2020","unstructured":"Ball MW, An JY, Gomella PT et al (2020) Growth rates of genetically defined renal tumors: implications for active surveillance and intervention. J Clin Oncol 38:1146\u20131153. https:\/\/doi.org\/10.1200\/JCO.19.02263","journal-title":"J Clin Oncol"},{"key":"6562_CR42","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/S0022-5347(01)66674-6","volume":"154","author":"MM Walther","year":"1995","unstructured":"Walther MM, Lubensky IA, Venzon D et al (1995) Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol 154:2010\u20132014 discussion 2014\u20132015","journal-title":"J Urol"},{"key":"6562_CR43","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","volume":"14","author":"ML Nickerson","year":"2008","unstructured":"Nickerson ML, Jaeger E, Shi Y et al (2008) Improved Identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res 14:4726\u20134734. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4921","journal-title":"Clin Cancer Res"},{"key":"6562_CR44","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/JCO.2015.65.6140","volume":"34","author":"SM Nielsen","year":"2016","unstructured":"Nielsen SM, Rhodes L, Blanco I et al (2016) Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. JCO 34:2172\u20132181. https:\/\/doi.org\/10.1200\/JCO.2015.65.6140","journal-title":"JCO"},{"key":"6562_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.euros.2025.10.009","volume":"82","author":"C Re","year":"2025","unstructured":"Re C, Pecoraro A, Stewart GD et al (2025) Genetic testing and counselling for hereditary renal carcinoma: what do clinicians need to know? Eur Urol Open Sci 82:131\u2013141. https:\/\/doi.org\/10.1016\/j.euros.2025.10.009","journal-title":"Eur Urol Open Sci"},{"key":"6562_CR46","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1582-4934.2007.00122.x","volume":"11","author":"L Santarpia","year":"2007","unstructured":"Santarpia L, Sarlis NJ, Santarpia M et al (2007) Mosaicism in von Hippel-Lindau disease: an event important to recognize. J Cell Mol Medi 11:1408\u20131415. https:\/\/doi.org\/10.1111\/j.1582-4934.2007.00122.x","journal-title":"J Cell Mol Medi"},{"key":"6562_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2350-11-4","volume":"11","author":"A Rasmussen","year":"2010","unstructured":"Rasmussen A, Alonso E, Ochoa A et al (2010) Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease. BMC Med Genet 11:4. https:\/\/doi.org\/10.1186\/1471-2350-11-4","journal-title":"BMC Med Genet"},{"key":"6562_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/GIM.0b013e3182091a1d","volume":"13","author":"CRM Lammens","year":"2011","unstructured":"Lammens CRM, Aaronson NK, Hes FJ et al (2011) Compliance with periodic surveillance for von-Hippel-Lindau disease. Genet Med 13:519\u2013527. https:\/\/doi.org\/10.1097\/GIM.0b013e3182091a1d","journal-title":"Genet Med"},{"key":"6562_CR49","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0000000000002064","volume":"85","author":"MLM Binderup","year":"2015","unstructured":"Binderup MLM, Budtz-J\u00f8rgensen E, Bisgaard ML (2015) New von Hippel\u2013Lindau manifestations develop at the same or decreased rates in pregnancy. Neurology 85:1500\u20131503. https:\/\/doi.org\/10.1212\/WNL.0000000000002064","journal-title":"Neurology"},{"key":"6562_CR50","first-page":"B5461","volume":"65","author":"MLM Binderup","year":"2018","unstructured":"Binderup MLM (2018) Von Hippel-Lindau disease: diagnosis and factors influencing disease outcome. Dan Med J 65:B5461","journal-title":"Dan Med J"},{"key":"6562_CR51","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY (2024) Renal cell carcinoma: a review. JAMA 332:1001. https:\/\/doi.org\/10.1001\/jama.2024.12848","journal-title":"JAMA"},{"key":"6562_CR52","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jmedgenet-2017-104995","volume":"55","author":"J-Y Wang","year":"2018","unstructured":"Wang J-Y, Peng S-H, Li T et al (2018) Risk factors for survival in patients with von Hippel-Lindau disease. J Med Genet 55:322\u2013328. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104995","journal-title":"J Med Genet"},{"issue":"8","key":"6562_CR53","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.1970.03170080067026","volume":"211","author":"JE Clark","year":"1970","unstructured":"Clark JE (1970) Transplantation for bilateral renal tumors. JAMA 211:1379","journal-title":"JAMA"},{"key":"6562_CR54","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0022-5347(17)58523-7","volume":"117","author":"CD Fetner","year":"1977","unstructured":"Fetner CD, Barilla DE, Scott T et al (1977) Bilateral renal cell carcinoma in Von Hippel-Lindau syndrome: treatment with staged bilateral nephrectomy and hemodialysis. J Urol 117:534\u2013536. https:\/\/doi.org\/10.1016\/S0022-5347(17)58523-7","journal-title":"J Urol"},{"key":"6562_CR55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000185042","volume":"49","author":"J Black","year":"1988","unstructured":"Black J, Rotellar C, Rakowski TA, Winchester JF (1988) Bilateral nephrectomy and dialysis as an option for patients with bilateral renal cancer. Nephron 49:150\u2013153. https:\/\/doi.org\/10.1159\/000185042","journal-title":"Nephron"},{"key":"6562_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000185681","volume":"52","author":"JP Charmes","year":"1989","unstructured":"Charmes JP, Calamai M, Peyronnet P et al (1989) Prognosis on dialysis of 31 patients after bilateral nephrectomy for bilateral renal cancer. Nephron 52:365\u2013366. https:\/\/doi.org\/10.1159\/000185681","journal-title":"Nephron"},{"key":"6562_CR57","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1097\/00007890-199712270-00017","volume":"64","author":"DA Goldfarb","year":"1997","unstructured":"Goldfarb DA, Neumann HPH, Penn I, Novick AC (1997) Results of renal transplantation in patients with renal cell carcinoma and Von Hippel-Lindau disease1,2. Transplantation 64:1726\u20131729. https:\/\/doi.org\/10.1097\/00007890-199712270-00017","journal-title":"Transplantation"},{"key":"6562_CR58","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0022-5347(17)37604-8","volume":"147","author":"AC Novick","year":"1992","unstructured":"Novick AC, Streem SB (1992) Long-term followup after nephron sparing surgery for renal cell carcinoma in Von Hippel-Lindau disease. J Urol 147:1488\u20131490. https:\/\/doi.org\/10.1016\/S0022-5347(17)37604-8","journal-title":"J Urol"},{"key":"6562_CR59","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MOU.0000000000000094","volume":"24","author":"AR Metwalli","year":"2014","unstructured":"Metwalli AR, Linehan WM (2014) Nephron-sparing surgery for multifocal and hereditary renal tumors. Curr Opin Urol 24:466\u2013473. https:\/\/doi.org\/10.1097\/MOU.0000000000000094","journal-title":"Curr Opin Urol"},{"key":"6562_CR60","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","volume":"161","author":"MM Walther","year":"1999","unstructured":"Walther MM, Choyke PL, Glenn G et al (1999) Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161:1475\u20131479. https:\/\/doi.org\/10.1016\/S0022-5347(05)68930-6","journal-title":"J Urol"},{"key":"6562_CR61","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","volume":"165","author":"JC Herring","year":"2001","unstructured":"Herring JC, Enquist EG, Chernoff A et al (2001) Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 165:777\u2013781","journal-title":"J Urol"},{"key":"6562_CR62","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5173\/ceju.2020.0004","volume":"73","author":"DM Cariion","year":"2020","unstructured":"Cariion DM, Linares-Espin\u00f3s E, R\u00edos Gonz\u00e1lez E et al (2020) Invasive management of renal cell carcinoma in von Hippel-Lindau disease. Cent Eur J Urol 73:167\u2013172. https:\/\/doi.org\/10.5173\/ceju.2020.0004","journal-title":"Cent Eur J Urol"},{"key":"6562_CR63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.15586\/jkcvhl.2015.41","volume":"2","author":"K Ashouri","year":"2015","unstructured":"Ashouri K, Mohseni S, Tourtelot J et al (2015) Implications of Von Hippel-Lindau syndrome and renal cell carcinoma. J Kidney Cancer VHL 2:163\u2013173. https:\/\/doi.org\/10.15586\/jkcvhl.2015.41","journal-title":"J Kidney Cancer VHL"},{"key":"6562_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.juro.2010.09.032","volume":"185","author":"AT Fadahunsi","year":"2011","unstructured":"Fadahunsi AT, Sanford T, Linehan WM et al (2011) Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol 185:49\u201353. https:\/\/doi.org\/10.1016\/j.juro.2010.09.032","journal-title":"J Urol"},{"key":"6562_CR65","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/S0022-5347(01)67318-X","volume":"153","author":"F Steinbach","year":"1995","unstructured":"Steinbach F, Novick AC, Zincke H et al (1995) Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol 153:1812\u20131816","journal-title":"J Urol"},{"key":"6562_CR66","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.juro.2010.01.010","volume":"183","author":"NW Liu","year":"2010","unstructured":"Liu NW, Khurana K, Sudarshan S et al (2010) Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol 183:1719\u20131724. https:\/\/doi.org\/10.1016\/j.juro.2010.01.010","journal-title":"J Urol"},{"key":"6562_CR67","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.juro.2008.03.030","volume":"180","author":"A Johnson","year":"2008","unstructured":"Johnson A, Sudarshan S, Liu J et al (2008) Feasibility and Outcomes of Repeat Partial Nephrectomy. J Urol 180:89\u201393. https:\/\/doi.org\/10.1016\/j.juro.2008.03.030","journal-title":"J Urol"},{"key":"6562_CR68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.juro.2007.08.150","volume":"179","author":"G Bratslavsky","year":"2008","unstructured":"Bratslavsky G, Liu JJ, Johnson AD et al (2008) Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol 179:67\u201370. https:\/\/doi.org\/10.1016\/j.juro.2007.08.150","journal-title":"J Urol"},{"key":"6562_CR69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","volume":"172","author":"BG Duffey","year":"2004","unstructured":"Duffey BG, Choyke PL, Glenn G (2004) THE relationship between renal tumor size and metastases in patients with Von Hippel-Lindau disease. J Urol 172:63\u201365. https:\/\/doi.org\/10.1097\/01.ju.0000132127.79974.3f","journal-title":"J Urol"},{"key":"6562_CR70","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.juro.2007.11.047","volume":"179","author":"DA Kunkle","year":"2008","unstructured":"Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, Ablate or Observe: the small renal mass dilemma\u2014a meta-analysis and review. J Urol 179:1227\u20131234. https:\/\/doi.org\/10.1016\/j.juro.2007.11.047","journal-title":"J Urol"},{"key":"6562_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-004-2360-y","author":"A Mahnken","year":"2004","unstructured":"Mahnken A, G\u00fcnther R, Tacke J (2004) Radiofrequency ablation of renal tumors. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-004-2360-y","journal-title":"Eur Radiol"},{"key":"6562_CR72","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2021.10.022","volume":"48","author":"VW-S Chan","year":"2022","unstructured":"Chan VW-S, Lenton J, Smith J et al (2022) Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: a longitudinal observational study. Eur J Surg Oncol 48:672\u2013679. https:\/\/doi.org\/10.1016\/j.ejso.2021.10.022","journal-title":"Eur J Surg Oncol"},{"key":"6562_CR73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.clgc.2017.07.027","volume":"16","author":"M Allasia","year":"2018","unstructured":"Allasia M, Soria F, Battaglia A et al (2018) Radiofrequency ablation for renal cancer in Von Hippel\u2013Lindau syndrome patients: a prospective cohort analysis. Clin Genitourin Cancer 16:28\u201334. https:\/\/doi.org\/10.1016\/j.clgc.2017.07.027","journal-title":"Clin Genitourin Cancer"},{"key":"6562_CR74","doi-asserted-by":"publisher","first-page":"5669","DOI":"10.2147\/OTT.S190753","volume":"13","author":"S Gl\u00e4sker","year":"2020","unstructured":"Gl\u00e4sker S, Vergauwen E, Koch CA et al (2020) Von Hippel-Lindau disease: current challenges and future prospects. OTT Vol 13:5669\u20135690. https:\/\/doi.org\/10.2147\/OTT.S190753","journal-title":"OTT Vol"},{"key":"6562_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157094","volume":"26","author":"J Kucharczyk","year":"2025","unstructured":"Kucharczyk J, Bhatt A, Bauer L, Economides M (2025) Belzutifan-associated hypoxia: a review of the novel therapeutic, proposed mechanisms of hypoxia, and management recommendations. Int J Mol Sci 26:7094. https:\/\/doi.org\/10.3390\/ijms26157094","journal-title":"Int J Mol Sci"},{"key":"6562_CR76","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251317846","volume":"17","author":"X Wu","year":"2025","unstructured":"Wu X, Lazris D, Wong R, Tykodi SS (2025) Belzutifan for the treatment of renal cell carcinoma. Ther Adv Med Oncol 17:17588359251317846. https:\/\/doi.org\/10.1177\/17588359251317846","journal-title":"Ther Adv Med Oncol"},{"key":"6562_CR77","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","volume":"385","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Donskov F, Iliopoulos O et al (2021) Belzutifan for renal cell carcinoma in von Hippel\u2013Lindau disease. N Engl J Med 385:2036\u20132046. https:\/\/doi.org\/10.1056\/NEJMoa2103425","journal-title":"N Engl J Med"},{"key":"6562_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf433","volume":"31","author":"A Baron","year":"2026","unstructured":"Baron A, Broekman E, van Gils M et al (2026) The European medicines agency review of belzutifan (Welireg) for the treatment of adult patients with von Hippel-Lindau disease-associated tumors. Oncologist 31:oyaf433. https:\/\/doi.org\/10.1093\/oncolo\/oyaf433","journal-title":"Oncologist"},{"key":"6562_CR79","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41585-024-00874-y","volume":"21","author":"A Larcher","year":"2024","unstructured":"Larcher A, Belladelli F, Cei F et al (2024) Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease. Nat Rev Urol 21:565\u2013571. https:\/\/doi.org\/10.1038\/s41585-024-00874-y","journal-title":"Nat Rev Urol"},{"key":"6562_CR80","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(22)01059-5","volume":"400","author":"GD Stewart","year":"2022","unstructured":"Stewart GD, Klatte T, Cosmai L et al (2022) The multispeciality approach to the management of localised kidney cancer. The Lancet 400:523\u2013534. https:\/\/doi.org\/10.1016\/S0140-6736(22)01059-5","journal-title":"The Lancet"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06562-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06562-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06562-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:22:28Z","timestamp":1782760948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06562-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6562"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06562-3","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is narrative review article does not include identifiable patient information. Accordingly, institutional review board (IRB) approval were not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This is a narrative review article that does not include identifiable patient information, and there is no need for informed participation consent to be declared, accordingly.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research invloving human participants and\/or animals"}}],"article-number":"473"}}